Ocrelizumab (Ocrevus) (Hoffmann-La roche limited)
The objective of this systematic review is to examine the beneficial and harmful effects of ocrelizumab treatment for the suppression of relapses and disease progression in adult patients with relapsing forms of multiple sclerosis (MS)
Corporate Author: | |
---|---|
Format: | eBook |
Language: | English |
Published: |
Ottawa (ON)
CADTH
2017, December 2017
|
Series: | CADTH common drug review clinical review report
|
Subjects: | |
Online Access: | |
Collection: | National Center for Biotechnology Information - Collection details see MPG.ReNa |
Summary: | The objective of this systematic review is to examine the beneficial and harmful effects of ocrelizumab treatment for the suppression of relapses and disease progression in adult patients with relapsing forms of multiple sclerosis (MS) |
---|---|
Item Description: | "Version 1.0." |
Physical Description: | 1 PDF file (118 pages) illustrations |